Good Clinical Practice: Considerations for Trials with Pragmatic or Decentralized Features

On September 12 and 13, the Foundation, in collaboration with the U.S. Food and Drug Administration, hosted a webinar to explore Good Clinical Practice Considerations for Trials with Pragmatic or Decentralized Features. We convened international experts in the conduct of clinical trials with pragmatic or decentralized features.

Reagan-Udall Foundation for the FDA Names 2023-24 Fellow in Regulatory Science, Innovation, and Health Equity

(August 15, 2023) The Reagan-Udall Foundation for the FDA has selected Kendra Getaw, PharmD, as its 2023-24 Fellow in Regulatory Science, Innovation, and Health Equity. Her year-long role, which began July 2023, includes activities across the Foundation.